BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28419815)

  • 1. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
    Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
    Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast MR imaging screening in women with a history of breast conservation therapy.
    Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Ozonoff A; Miller JP; Kalinyak JE
    Radiology; 2011 Jan; 258(1):59-72. PubMed ID: 21076089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
    van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
    Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study.
    Lehman CD; Isaacs C; Schnall MD; Pisano ED; Ascher SM; Weatherall PT; Bluemke DA; Bowen DJ; Marcom PK; Armstrong DK; Domchek SM; Tomlinson G; Skates SJ; Gatsonis C
    Radiology; 2007 Aug; 244(2):381-8. PubMed ID: 17641362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
    Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
    Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer.
    Kim JY; Cho N; Koo HR; Yi A; Kim WH; Lee SH; Chang JM; Han W; Moon HG; Im SA; Noh DY; Moon WK
    Radiology; 2013 Apr; 267(1):57-66. PubMed ID: 23329656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
    Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    Vreemann S; Gubern-Mérida A; Borelli C; Bult P; Karssemeijer N; Mann RM
    PLoS One; 2018; 13(1):e0191399. PubMed ID: 29351560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric
    Leithner D; Helbich TH; Bernard-Davila B; Marino MA; Avendano D; Martinez DF; Jochelson MS; Kapetas P; Baltzer PAT; Haug A; Hacker M; Tanyildizi Y; Morris EA; Pinker K
    J Nucl Med; 2020 Jan; 61(1):20-25. PubMed ID: 31253745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.